Moderna Inc. (MRNA)

18.07
NASDAQ : Health Technology
Prev Close 17.90
Day Low/High 17.75 / 18.39
52 Wk Low/High 11.54 / 29.79
Avg Volume 1.83M
Exchange NASDAQ
Shares Outstanding 330.18M
Market Cap 5.91B
EPS -5.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Moderna Appoints Tracey Franklin As Chief Human Resources Officer

Moderna Appoints Tracey Franklin As Chief Human Resources Officer

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Tracey Franklin has been appointed...

Moderna To Host R&D Day On September 12, 2019

Moderna To Host R&D Day On September 12, 2019

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host its third annual R&D Day...

Moderna To Present At Upcoming Investor Conferences

Moderna To Present At Upcoming Investor Conferences

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced its participation in the following upcoming...

Moderna Stock Surges as FDA Fast Tracks Zika Vaccine

Moderna Stock Surges as FDA Fast Tracks Zika Vaccine

The biotech's investigational Zika vaccine is being evaluated in a Phase I study.

Moderna Receives FDA Fast Track Designation For Zika Vaccine MRNA-1893

Moderna Receives FDA Fast Track Designation For Zika Vaccine MRNA-1893

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.

Moderna Provides Business Updates And Reports Second Quarter 2019 Financial Results

Moderna Provides Business Updates And Reports Second Quarter 2019 Financial Results

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results for the second quarter of...

Moderna To Report Second Quarter 2019 Financial Results On Wednesday, August 7th, 2019

Moderna To Report Second Quarter 2019 Financial Results On Wednesday, August 7th, 2019

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call...

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Jim Cramer says higher sales, higher prices, and demand from emerging markets seem to be fueling a return to the days of great senior growth stocks.

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Jim Cramer weighs in on Pfizer, eBay, Cloudera, Cadence Systems, CRISPR Therapeutics, Moderna, Tandem Diabetes Care, and more.

Moderna To Present At ROTH RNA Revolution Conference

Moderna To Present At ROTH RNA Revolution Conference

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Lorence Kim, M.

Moderna To Present At BMO 2019 Prescriptions For Success Healthcare Conference

Moderna To Present At BMO 2019 Prescriptions For Success Healthcare Conference

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Pamela Cohen, M.

Moderna To Present At Goldman Sachs 40th Annual Global Healthcare Conference

Moderna To Present At Goldman Sachs 40th Annual Global Healthcare Conference

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Stephane Bancel, Chief Executive...

Moderna, Six Flags, Chevron and More: 'Mad Money' Lightning Round

Moderna, Six Flags, Chevron and More: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

We're in Bizarro Land: Cramer's 'Mad Money' Recap (Wednesday 6/5/19)

Investors should consider recession-proof names in the current environment, Jim Cramer says.

Moderna Announces Presentation Of Interim Data From Phase 1 Study Of MRNA Personalized Cancer Vaccine At 2019 ASCO Annual Meeting

Moderna Announces Presentation Of Interim Data From Phase 1 Study Of MRNA Personalized Cancer Vaccine At 2019 ASCO Annual Meeting

Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced interim data from an ongoing Phase 1...

Moderna Announces Publication Of Preclinical Data For Chikungunya Antibody Program

Moderna Announces Publication Of Preclinical Data For Chikungunya Antibody Program

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the publication of preclinical data in...

Moderna Announces Publication Of Phase 1 Data For MRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna Announces Publication Of Phase 1 Data For MRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the publication of results from two Phase 1...

Moderna Reports First Quarter 2019 Financial Results And Provides Business Updates

Moderna Reports First Quarter 2019 Financial Results And Provides Business Updates

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results for the first quarter of...

Moderna To Present At Bank Of America Merrill Lynch 2019 Health Care Conference

Moderna To Present At Bank Of America Merrill Lynch 2019 Health Care Conference

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Tal Zaks, M.

Moderna To Present Preclinical Data At 2019 American Society Of Gene & Cell Therapy (ASGCT) Annual Meeting

Moderna To Present Preclinical Data At 2019 American Society Of Gene & Cell Therapy (ASGCT) Annual Meeting

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will present, along with academic...

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

These Stocks Are Too Hot: Cramer's 'Mad Money' Recap (Thursday 4/18/19)

Cramer says these red-hot and hopelessly overvalued IPOs are signs people are too bullish. Here's your game plan for next week.

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Kraft Heinz, PepsiCo, Marvell Technology: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Kraft Heinz, PepsiCo, Marvell Technology, General Mills, Funko, Signet Jewelers, Abiomed and more.

Moderna To Host Science Day On May 7, 2019 And Report First Quarter Financial Results On May 8, 2019

Moderna To Host Science Day On May 7, 2019 And Report First Quarter Financial Results On May 8, 2019

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host its annual Science Day...

McDonald's, Moderna, Twilio: 'Mad Money' Lightning Round

McDonald's, Moderna, Twilio: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at McDonald's, Moderna, Illinois Tool Works, Twilio and more.

Top-Callers Are Back: Cramer's 'Mad Money' Recap (Tuesday 4/9/19)

Top-Callers Are Back: Cramer's 'Mad Money' Recap (Tuesday 4/9/19)

Jim Cramer says a garden-variety pullback is reasonable, but don't be spooked by pundits and portfolio managers.

Moderna To Present At 18th Annual Needham Healthcare Conference

Moderna To Present At 18th Annual Needham Healthcare Conference

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Tal Zaks, M.

Moderna Reports 2018 Fourth Quarter And Full Year Financial Results And Highlights Recent Pipeline Progress

Moderna Reports 2018 Fourth Quarter And Full Year Financial Results And Highlights Recent Pipeline Progress

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results for the fourth quarter and...

Buy or Sell the News?: Cramer's 'Mad Money' Recap (Monday 3/4/19)

Buy or Sell the News?: Cramer's 'Mad Money' Recap (Monday 3/4/19)

Jim Cramer analyzes what's driving the sellers and looks into this out-of-high-growth-into-value rotation.